| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Evonetix Ltd Technology to ignite the biology revolution We are a Cambridge-based company developing a radically different approach to gene synthesis. Our desktop DNA synthesis platform will provide the ability to synthesise DNA at unprecedented accuracy, scale and speed, accelerating scientists' ability to use synthetic biology on a scale not currently possible. Biotechnology, Synthetic Biology, DNA synthesis, Gene synthesis, and synbio Type: | 3 | 0 | 3 | 32 |
 | Hemab Therapeutics The next generation of therapeutics for bleeding and thrombotic disorders Hemab is a clinical-stage biotech company developing the first prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders. Based in Cambridge, Massachusetts and Copenhagen, Denmark, Hemab is progressing a pipeline of monoclonal and bispecific antibody-based therapeutics to transform the treatment paradigm for patients with high unmet need. The company’s strategic guidance, Hemab 1-2-5, targets the development of 5 clinical assets by 2025 to deliver long-awaited innovation for patients with high unmet need blood clotting disorders like Glanzmann Thrombasthenia, factor VII deficiency, Bernard Soulier Syndrome, Von Willebrand Disease and other serious … Type: | 1 | 0 | 1 | 49 |
 | TissueLabs The platform for creating organs and tissues in the lab. The platform for creating organs and tissues in the lab. Biotechnology, Biomaterials, Bioprinting, 3D Cell Culture, Tissue Engineering, Hydrogels, Regenerative Medicine, Research, and Tissue Culture Type: | 3 | 1 | 1 | 14 |
 | Tetra Pharm Technologies We do science Tetra Pharm is a research focused biopharmaceutical company. Type: | 2 | 0 | 2 | 43 |
 |  Amferia kills bacteria Amferia kills bacteria, even resistant bacteria, without harming the body Amferia AB is a Swedish company that develops and markets new medical devices with emphasis on antibacterial products. The core focus of Amferia is to develop materials that can efficiently kill bacteria when used as medical devices, for example within wound care. Amferia is a spin-off from research performed at Chalmers University of Technology. The company was founded in 2018 and the founders of Amferia are Dr. Anand Kumar Rajasekharan, Professor Martin Andersson and Dr. Saba Atefyekta. Antibacterial materials, Antibiotic resistance, Elastomers, and Injectable Materials Type: | 0 | 0 | 0 | 13 |
 | Machine Bio Machine Bio is a biotech company offering unique protein synthesis and purification solutions. Machine Bio is an early stage biotechnology company developing a novel, proprietary protein synthesis platform that can produce pure protein from a DNA template in a easy-to-use, single-step, 4 hour process. Proteins are broadly used in many industries and Machine Bio’s platform has a range of possible applications across drug discovery and development, synthetic biology research, industrial enzyme optimization, and commercial therapeutic manufacturing. Protein Synthesis, Protein Purification, Contract Protein Expression, R&D, Startup, Cell-Free Systems, and Supported Lipid Bilayer Type: | 1 | 1 | 0 | 3 |
 | ExeVir Rapid Viral control in a world that needs it Exevir Bio is a biotech company developing efficacious heavy chain-only antibodies to prevent and treat infectious diseases and make a difference in pandemic preparedness. The technology platform of ExeVir uses humanized camelid heavy chain-only antibody fragments (VHH) fused to a human IgG Fc to create new therapeutic compounds. ExeVir is building a strong pipeline of antibody therapies with an initial focus on COVID-19 and dengue. Compared to conventional monoclonal antibodies, the modular VHH building blocks provide a unique combinatory flexibility. In addition, the design of multi-specific constructs is substantially simplified. VHHs … Type: | 3 | 0 | 2 | 20 |
 | NapiFeryn BioTech We developed and patented a #technology to obtain #food grade #proteins from #rapeseed (#canola) and other oilseeds. Beneficiary of #SMEInstrument #H2020 and the proud member of #RisingFoodStars #EITFood The NapiFeryn technology makes it possible to retrieve all protein contained in rapeseed, which makes the proposal unique worldwide. biotechnology, food industry, alternative proteins, rapeseed protein, and raptein Type: | 6 | 2 | 5 | 19 |
 | DeuterOncology NV Developing deuterated BEST in CLASS MET kinase Inhibitor DeuterOncology NV is a Liege based clinical stage biotechnology company that was founded in September 2020 by Dr Timothy Perera. The company is currently focused on the clinical development of a highly selective brain penetrant, deuterated MET kinase inhibitor DO-2. Drug Development, Deuterated small molecules, and MET kinase inhibitor Type: | 0 | 0 | 0 | 5 |
 | Rewind Therapeutics Rewind Therapeutics is developing first-in-class remyelinating therapies for myelin-related diseases and aims to bring them into fast-track clinical development. Myelin-related diseases, such as multiple sclerosis, are those where the myelin sheath surrounding nerves is damaged leading to deficient nerve transmission that may affect multiple functions, including sensation, cognition and movement, among others. The causes of damage may be genetic, a result of infectious or autoimmune disease or from exposure to toxic agents or other forms of brain injury. There is no cure for demyelinating diseases. The Company was founded by KU Leuven’s Centre for Drug Design and Discovery (CD3) and … Type: | 0 | 0 | 0 | 20 |
 | NeoPhore Ltd Discovering drugs that create neoantigens NeoPhore, UK is focused on the discovery and development of novel small molecule therapies to treat cancer through stimulation of the immune system. Generation of cancer neoantigens in tumours can be exploited by the patients’ immune system to overcome natural defence mechanisms in cancer. The Company’s approach targets the DNA mismatch repair (MMR) pathway, which has been proven to promote neoantigen creation and subsequent immunity against numerous cancers. Using these insights, NeoPhore aims to generate next-generation immuno-oncology therapeutics to improve clinical outcomes for cancer patients. NeoPhore was spun-out of the University of Turin and PhoreMost … Type: | 1 | 0 | 1 | 17 |
 | QV Bioelectronics Delivering longer, better quality lives for brain tumour patients QV Bioelectronics is a VC-backed medical device startup developing an implantable electric field therapy treatment for aggressive brain tumours. Type: | 4 | 0 | 4 | 16 |
 | MgShell S.r.l. La sfida che ci proponiamo è quella di rivoluzionare completamente l'approccio terapeutico nel campo oftalmico. The hard clinical context related to the age-related macular degeneration or maculopathy, chronic ocular disease and first cause of blindness in developed countries, has to be solved. The number of affected patients is increasing drastically with 500'000 new cases per year and a pool of 260 million patients is estimated for 2040. Despite the noted efficacy of the drug, the intravitreal injections to which patients are subjected monthly implies a high rate of treatment dropout, followed by a very high risk of irreversible blindness condition. … Type: | 2 | 0 | 1 | 5 |
 | Neuria SA Solutions for behavioral change and rehabilitation Neuria is an award-winning Swiss company developing science-based solutions to improve public health. Our team of neuroscientists, engineers and gaming professionals provides software and solutions for large-scale behavioral change interventions, neuropsychiatric remediation and to facilitate scientific research. Neuria is the first worldwide to propose evidence-based Dtx to modulate the brain reward system to restore healthy consumption behaviors and improve health. Digital therapeutics, Gamification, Health care, Public Health, and Online interventions Type: | 2 | 0 | 1 | 10 |
 | Refined Laser Systems GmbH Label-free and chemically specific imaging for life science and medical diagnostics Refined is a young biophotonics company from Münster, Germany, aiming to transform the treatment of cancer. During today's cancer treatments, surgeries must be repeated in up to one third of all cases because it remains a challenge to quickly identify cancer cells without extensive biopsy processing. With its pioneering laser technology, combined with advanced microscopy methods and artificial intelligence, Refined has stepped up to empower surgeons and pathologists to overcome this challenge. fiber laser, picosecond laser, 2-photon microscopy, and microscopy Type: | 2 | 0 | 2 | 14 |
 | Humane Genomics Platform to engineer cancer killing viruses using synthetic biology. Humane Genomics is developing a platform to engineer cancer killing viruses with unprecedented specificity and efficiency. Our first indication is liver cancer. We are based in New York City and backed by amazing investors. (YC S21) Type: | 5 | 1 | 5 | 5 |
 | Actipulse Neuroscience® Neuromodulation therapeutics from the hospital, directly to the home of the patient. A Paris Brain Institute company. Non-invasive brain stimulation is a widely-utilized, FDA cleared treatment used for patients diagnosed with depression, but is limited to a hospital setting due to the cost of the device, and complexity of treatment application. Our proprietary brain stimulation device allows patients to be treated directly from their home, with the same efficacy, and at a lower cost of treatment. Neuromodulation, Depression, Alzheimer's, and Neurotech Type: | 5 | 4 | 0 | 38 |
 | Octarine Bio We're harnessing nature to drive sustainable solutions Pioneering new sustainable bio-based ingredients Synthetic Biology, Fermentation, Yeast metabolism, Plant metabolism, and Metabolic engineering Type: | 3 | 2 | 1 | 28 |
 | Mondarella Plant-based cheese redefined. Super tasty, clean label, high nutritional value - cheese craft meets bio-tech. Mondarella Homepage plant-based cheese, vegan cheese, food-tech, food bio-tech, food innovation, plant-based, cheese , startup, and alternative protein Type: | 1 | 0 | 0 | 29 |
 | Monument Therapeutics Bringing Precision Medicine to Neuroscience Drug Development Monument Tx is an independent UK based biotechnology company formed as a spin-out from Cambridge Cognition in 2021. Monument Tx develops products to treat serious diseases of the central nervous system. Our precision medicine approach utilises proprietary digital biomarkers to reduce heterogeneity and identify patients with homogenous underlying neurobiology, which are then matched with appropriately targeted compounds. Using biomarkers to more accurately identify patients with a disease sub-type most likely to respond to a particular treatment is already successfully used in the treatment of cancer. Now Monument Tx brings digital biomarkers to neuroscience … Type: | 0 | 0 | 0 | 6 |
 | CELLUGY® Creating sustainable materials to replace fossil based material/polymer through biofabrication! We are a Danish biotech startup based in Søborg, with global ambition. We created superior material from nature's most abundant building block, cellulose. biodegradable material, sustainable material, plastic replacement, environmental packaging, green technology, biotechnology, personal care, textiles, cellulose, personal care products, and cosmetics Type: | 7 | 3 | 0 | 22 |
 | Tandem Therapeutics Unlocking the matrix barrier to treat fibrotic diseases TANDEM Therapeutics is a discovery stage Swiss biopharmaceutical company bringing a novel precision targeting approaches to fibrosis and fibrotic cancers. We advance over 15 years of transformative research and development at ETH Zürich and Paul Scherrer Institut in the field of extracellular matrix biology and the critical role it plays in the pathology of fibrotic cancers & organ fibrosis. The therapeutic platform is based on Matrix Targeting Peptides (MTP) that conditionally target disease associated matrix alterations that are known to be directly associated with several fibrotic diseases. Type: | 0 | 0 | 0 | 5 |
 |  Allegria Therapeutics Mastering Mast Cells Allegria Therapeutics was founded in Basel, Switzerland by Forty51 Ventures in 2023. Pursuing a differentiated portfolio of proprietary therapeutic approaches around biological targets that selectively modulate mast cells, Allegria plans to redefine the treatment landscape for allergy and mast cell-mediated inflammatory diseases. For more information, please visit www.allegriatx.com Mast Cell-Targeted Therapeutics, Allergy, and Inflammatory Disease Type: | 0 | 0 | 0 | 2 |
 | Metsystem Personalized cancer patient treatment that targets metastasis. Personalized cancer patient treatment that targets metastasis. We can treat preventatively and create better patient outcome. Metsystem is developing a metastasis-targeting drug screen platform that is capable of predicting the most effective drug for each patient. With an accurate drug screen we can guide treatment and create better patient outcomes. Type: | 3 | 1 | 2 | 19 |
 | Point Pressure Developing the next big leap in spasticity treatments. Point Pressure is developing a medical device to help patients with chronic diseases or conditions experiencing spasticity through a non-invasive physical treatment. The main aim of the instrument is to treat spasticity symptoms resulting in a wider motion of the affected limbs. Type: | 2 | 1 | 0 | 9 |
 | NeuroBell Medical device company developing newborn brain monitoring solutions. Neurobell develop novel products for early detection and monitoring of neonatal seizures to facilitate better treatment and patient outcomes. Type: | 2 | 0 | 1 | 12 |
 | Cellsway Cellsway is a fresh deep-tech start-up founded in March 2020 in UK to convert the know-how and cutting-edge core technology that have been developed and cultivated at Mikro Biyosistemler Inc. into commercial products to set the gold standard for diagnosis and management of cancer. The flagship product of the company is a liquid biopsy platform which uses a simple blood sample for cancer diagnostics and cancer research. The patent-pending microfluidic technology enables isolation and enumeration of Circulating Tumor Cells (CTCs) from the blood samples of cancer patients. Type: | 4 | 0 | 0 | 6 |
 | TrackPaw Scientific AB We digitalise preclinical studies to increase welfare and research quality. TrackPaw Scientific's deep tech solution for 24/7 monitoring of early stage pharmaceutical development offers improved animal welfare together with better study outcomes. Biotechnology , Drug development, Machine learning, Artificial Intelligence, Deep tech, Preclinical research, Animal welfare, and 3R Type: | 1 | 0 | 1 | 10 |
 | Synerkine Pharma Creating Innovative Pain Solutions Synerkine Pharma B.V. focuses on development of novel fusion proteins, called Synerkines, that combine the immunoregulatory activity of different cytokines. These fusion proteins have unique benefits over the individual cytokines and modulate a broad number of targets, including key elements in the pain pathway. This provides treatment options for chronic pain conditions with a clearly differentiated mechanism of action over current analgesic drugs and holds tremendous therapeutic and commercial potential. Synerkine Pharma B.V. was founded in 2018 as a spin-off of the University Medical Center Utrecht (UMCU), the Netherlands. Type: | 1 | 0 | 1 | 8 |
 | Egetis Therapeutics AB Pharmaceutical drug development company, focusing on late-stage development for treatment of serious rare diseases. Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment Type: | 0 | 0 | 0 | 47 |
 | Cirdan Ltd Leading provider of informatics software and imaging solutions that enhance and speed up the diagnosis of patients. Cirdan designs, manufactures and supplies innovative software and imaging solutions for the acceleration and enhancement of diagnosis. Our systems are optimised for pathology and clinical laboratory usage. Cirdan’s primary product is its world-class Laboratory Information System, ULTRA. ULTRA has been designed to streamline laboratory operations and is currently installed in more than 72 laboratories across 6 continents. Another core product is PathLite Compact, a purpose-built system designed specifically for gross imaging within clinical laboratories. The company was founded in 2010 and is headquartered … Type: | 3 | 0 | 2 | 103 |
 | ARTICA Therapeutics Development of covalent small molecules to transform the treatment of autoimmune and inflammatory disorders ARTICA Therapeutics and its seasoned team started operatons in 2020 and was supported by pre-Seed financing from BioGeneration Ventures. Artica is dedicated to developing novel small molecule medicines for inflammatory and autoimmune indicatons. Artca is at the forefront of covalent binding technology as well as in label-free cellular-based screening approaches. The unique combinaton of these capabilities allows rapid progression of the best drug candidates that have unprecedented and superior characteristics, creating novel and highly selective therapies for patients with unmet medical need. Type: | 1 | 0 | 0 | 17 |
 | Onena Medicines AI-centric preclinical company discovering and developing novel biopharmaceuticals to treat cancer and rare diseases Onena Medicines is a biopharmaceutical company with a pipeline of first-in-class antibody medicines to treat recurrent and metastatic cancers and selected rare diseases. Onena’s drugs neutralize a new class of secreted ancient growth factors, conserved across species, called Dual SMAD Inhibiting Proteins (DSIPs), that program cancer cells to grow and resist chemotherapy. Blocking DSIPs, as demonstrated in-vivo by Onena, simultaneously reactivates physiological TGF-β and BMP signaling and elicits cellular reprogramming, resulting in cancer cells accepting environmental cell death signals from BMPs and Activins. Onena has developed … Type: | 0 | 0 | 0 | 13 |
 | ImmuONE Specialised translational approaches and in vitro testing services ImmuONE specialises in human alveolar macrophage responses, epithelial cell culture platforms and testing services. Our respiratory tissue models closely resemble lung physiology to provide relevant, reliable, and reproducible results. ImmuONE is partnered with the industry and academia to develop sustainable technologies for the future to support human-relevant, mechanistic driven safety assessments and develop animal product-free cell models. We offer a range of standard and bespoke assessments for inhalation safety assessment needs. ImmuONE provides innovative solutions for inhalation toxicology, irritation sensitization, alveolar clearance, inflammation and can tailor to your inhalation safety assessment needs. … Type: | 5 | 0 | 4 | 17 |
 | ResoTher Pharma Building on innovative science to create treatments for patients in need ResoTher Pharma ApS is a biotechnology company focused on developing novel and effective peptide therapeutics for cardiovascular disease by targeting inflammation. Biotechnology, Drug Development, and Pharmaceutical Industry Type: | 0 | 0 | 0 | 17 |
 | Pixelgen Technologies Pioneering Spatial Proteomics for Single Cells Pixelgen Technologies AB was founded in 2020 by a team of passionate, experienced innovators and entrepreneurs with a vision to bring a new spatial understanding to biology by developing tools to facilitate the mapping of cell surface proteins and their spatial inter-relationships. Life operates by the spatial orchestration of proteins and at Pixelgen we have developed Molecular Pixelation that analyses cell surface proteins in a completely new way. Using current technologies, there are limitations of light and taking images influencing how many proteins and how many samples that can be analysed concurrently. With molecular … Type: | 0 | 0 | 0 | 29 |
 | LimmaTech Biologics AG Better technology for better health LimmaTech Biologics AG is a Swiss-based clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antibiotic resistance (AMR) and sexually transmitted diseases. In addition to our proprietary research, we also develop vaccines together with GSK. vaccines, research & development, biotechnology, and antimicrobial resistance Type: | 1 | 1 | 0 | 46 |
 | AstronauTx AstronauTx is tackling dementia through improving brain physiology AstronauTx is at the forefront of a novel approach to treating neurodegenerative diseases. We have a unique portfolio of small-molecule therapeutics to restore dysregulated physiology to both improve symptoms and modify disease. Type: | 2 | 0 | 1 | 14 |
 | Double Bond Pharmaceutical International AB Double Bond Pharmaceutical is a fast growing pharmaceutical company that develops and commercializes innovative first-in-class approaches for treatment of cancers, infections, autoimmune diseases and other life-threatening disorders. The main aim of the company is to provide patients and the market with more efficient and safe products especially in areas where these needs are unmet. The human population is growing and also the life-span is increasing. Many children born today can be expected to live until they are about 100 years old. By these reasons it can be expected that the need for efficient therapies for treatment of different diseases will … Type: | 0 | 0 | 0 | 14 |
 | Predictiv Care 🧬 DNA-based Digital Twin to help predict and prevent diseases and adverse reaction to drugs Personal genomics solution for predictive medicine—Thanks to unique and groundbreaking technology, Predictiv identifies the genetic predispositions of an individual on 22,000+ diseases and simulated reactions to 750+ drugs. Now enabling more accurate preventive actions and treatments. genomics, predictive medicine, preventive medicine, heathcare, and biotechnology Type: | 18 | 3 | 14 | 11 |
 | Age Labs AS Extending human healthspan Aging is the main cause behind most illnesses that eventually kill us. Your chance of dying doubles every 8 years. By the time you turn 80, half of your peers are dead. However, it turns out aging is a biological process, amenable to treatment. Research has demonstrated that we can postpone the onset of age-related disease. Lab mice know this already. Experiments with caloric restriction, senolytics and metabolic inhibitors have extended life and reversed aging - in mice. But how do we know these treatments will work in humans? We can wait and see if patients receiving … Type: | 0 | 0 | 0 | 4 |
 | Sigrid Therapeutics 100% Natural Stability For Your Blood Sugar Levels and Weight With science-backed, 100% natural solutions, we empower journeys toward balanced and healthier lives by optimizing metabolism and making well-being achievable every day. prediabetes, diabetes, blood sugar management, healthtech, obesity, innovation, medical device, biotech, and life science Type: | 2 | 1 | 2 | 19 |
 | HelloBetter Leading provider of prescription digital therapeutics (PDTx) for mental health with the strongest evidence base globally HelloBetter is a European leader in the field of digital therapeutics (DTx) for mental health and a global pioneer in digital mental health research. Founded in 2015, HelloBetter has the strongest evidence base globally, with a total of 33 randomized controlled trials published in peer-reviewed journals. In Germany, six of their therapy programmes are part of the standard of care and as such available to 70+ million people for free as prescription digital therapeutics or DiGA. In 2022, HelloBetter entered the US market with … Type: | 5 | 1 | 3 | 143 |
 | Carbiotix Pioneering onsite upcycling of plant-based side-streams Carbiotix is an award-winning biotechnology company pioneering the onsite upcycling of plant-based side-streams. Carbiotix mission is to improve the health of people by increasing the consumption of prebiotics and other active ingredients from upcycled side-streams. Carbiotix offers one core service today called NutraCycle, an on-site upcycling and fortification service allowing food & beverage, ingredient, and feed producers to turn plant-based products into healthier, more profitable, and sustainable products. Gut Health, Microbiome, Prebiotics, Upcycling, Plant-based, Food & Beverage, Ingredient, Feed, Biotechnology, Process Engineering, Product Design, Active Ingredients, and Onsite Type: | 0 | 0 | 0 | 17 |
 | Samsara Therapeutics Treating Neurodegenerative Disease by Restoring Autophagy At Samsara Therapeutics, we’re on a mission to unlock the full potential of autophagy activation in combating age-related neurodegenerative diseases. Our innovative approach aims to delay the progression of several debilitating conditions, offering new possibilities for patients and their families. biotechnology, biopharmaceuticals, rare disease, neurodegeneration, longevity, drug discovery, and drug development Type: | 1 | 0 | 1 | 20 |
 | SENISCA Applying world-leading molecular genetics to solve the diseases and aesthetic signs of ageing SENISCA is a biotech spinout company from the University of Exeter, founded in 2020 and dedicated to the development of new approaches to reverse cellular senescence (senotherapeutics). Our founders are world leaders in molecular and cellular biology and have patent-protected an innovation for the reversal of cellular senescence. This innovation works by restoring the ability of cells to ‘fine tune’ the expression of their genes to rejuvenate aged cells. At SENISCA, we are using this knowledge, concerning how and why cells become senescent, to develop a new … Type: | 1 | 0 | 1 | 23 |
 | Life Length Measuring life for the world Founded in 2010, Life Length stands out as a global leader in diagnostic biotechnology, specializing in telomere diagnostics. Our proprietary platform technology, TAT®, is based on the measurement of telomere variables and assays related to aging and age-related diseases. This patented technique allows quantification of telomere length at the individual cell level and is applicable to blood, cell culture and tissue samples. Recently, we have developed a biomarker for the early detection of prostate cancer with this technology. This biomarker is authorized by the AEMPS in Europe and by the CMS in the United States, … Type: | 2 | 1 | 2 | 50 |
 | Uncommon We’re using ground-breaking cell technologies to revolutionise global food production - starting with pork Powered by breakthrough technology, our vision of a mouth-watering, affordable and healthy protein is fast approaching - we’ve pioneered a strategy to scale cultivated meat that eliminates the industry’s largest cost driver with zero genetic engineering. Previously known as Higher Steaks Ltd, we’ve successfully scaled from a compact start-up to a dynamic company of 50+ creative scientists, engineers and operators, committed to a massive takeover of the food industry. We’ve developed a scalable production process that can cut costs, drastically reduce waste materials and improve the … Type: | 9 | 2 | 5 | 61 |
 | Magioni Veggie-based alternatives. Nutritious & damn tasty! We are Magioni and we believe in a world where you don’t have to choose between a healthy lifestyle and really good food. From that ambition we started and we did it. More nutritious veggie-based alternatives that are also really tasty. And that changes everything... Our products are a source of fiber and protein and by adding vegetables they contain various vitamins and minerals, no added sugars and they are also low in salt. Together we are challenging the food industry for change. Will you join the veggie revolution? Follow our pizza journey on … Type: | 1 | 1 | 0 | 14 |
 | Vivet Therapeutics Vivet Therapeutics is dedicated to developing innovative gene therapy treatments for orphan diseases. Vivet Therapeutics is focused on optimizing gene therapy through collaborating with the Fundacion para la Investigacion Medica Aplicada (CIMA, Universidad de Navarra) to develop new AAV vectors specifically targeting the liver and generating new technologies to optimize gene delivery and long term expression. Gene Therapy Type: | 4 | 1 | 2 | 32 |
 | Fox Innovation [Automatic translation follows] Relieve your back, preserve your health Personalized support for choosing the right exoskeleton Fox Innovation is a company founded in 2017. From the medical world, it supports employees and companies in their search for ergonomic solutions and prevention of the risks of musculoskeletal disorders (MSDs). From job analysis, on-site testing to certified training in the use of these innovative technologies, Fox Innovation has acquired recognized experience in exoskeletons installed today in France in all fields and for a very large number of different positions and professions Fox Innovation is more than 1000 company visits and more than … Type: | 7 | 0 | 4 | 3 |
 | GlioCure A preclinical-stage drug-development company specialized in neuro-oncology GlioCure, a spin-off company of Angers and McGill Montreal universities, aims to treat glioblastoma that causes 200,000 deaths worldwide each year. To overcome this challenge, GlioCure is hyper-specialized and develops glioblastoma-specific drugs. GlioCure is currently focusing on the development of GC01, an anti-glioblastoma peptide discovered by Joël Eyer, Director of Research from INSERM, and covered by two patent families for which GlioCure owns worldwide exclusive rights. GlioCure's team has the experience and the know-how to ensure the successful completion of GC01’s development plan: Louis-Marie is a biotech entrepreneur with 15 years of experience … Type: | 12 | 7 | 7 | 5 |
 | Cherry Biotech Alternative to Animal Testing for Drug Development Cherry Biotech is a biomedical technology (Organ on Chip) company that develops instruments for drug discovery and personalised medicine. Its mission is to replace animal testing by reconstructing human tissue (Organoids) in vitro for drug testing. Cherry Biotech's CUBIX platform enables pharmaceutical, biotech companies and healthcare providers to recreate immunocompetent human vascularized organ models and tumor microenvironments for better evaluation of their drug candidates. By enabling the reconstruction of human 3D models that mimic human physiology and pathophysiology over several weeks, Cherry Biotech's proprietary CUBIX technology is the only solution that can convert … Type: | 3 | 2 | 0 | 23 |
 | Pixium Vision S.A. Innovating at the frontier of neuroscience : brain machine interfacing the Eye and the Brain - from photons to neurons ! One must remember the notion that restoring some vision to those who have lost their sight is possible, has long been thought to be fanciful. However, we are in the Age of Neural Prostheses, Bioelectronics, and BMI. At frontier of neuroscience, interfacing the worlds of eye and the brain – “from Photons to Neurons”. Such is the breadth and depth of knowledge needed to build a world of bionic vision for those with vision loss. This is the mission … Type: | 10 | 7 | 3 | 22 |
 | Bioxis Pharmaceuticals #BeyondInnovation #DermalFiller #CYTOSIAL #AestheticMedicine New ideas, new innovations, new ways of thinking for the medical device industry. We are a pharmaceutical company specialized in the discovery, clinical development, production and commercialization of innovative products in the field of regenerative medicine. At Bioxis Pharmaceuticals, we contribute to transform science into groundbreaking medical device that meet doctors need to improve the health and well-being of their patients in the field of dermatology and aesthetic medicine. Medical Device, Dermatology, Aesthetic, Cosmetic surgery, Regenerative medicine, Ultra-pure chitosan, and Hyaluronic Acid Type: | 0 | 0 | 0 | 28 |
 | Acticor Biotech To treat the acute phase of ischemic stroke ! Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of an innovative therapeutic strategy for a safe and effective emergency treatment of ischemic strokes which account for 80% of all strokes. Acticor Biotech’s project stems from the sheer need for new therapeutic options to manage stroke. According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 5 million die and another 5 million are permanently disabled. Stroke is the third cause of death in the … Type: | 14 | 11 | 6 | 34 |
 | TRICARES TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system. Type: | 1 | 1 | 0 | 40 |
 | Insight Biosolutions Your safety passport for cosmetic ingredients & drug candidates Your partner for toxicological risk assessment requests Using our digital solutions increases the product safety and reduces the product development cost up by 30%. Insight Biosolutions (IBS) with his expert network has developed specialized platforms for in vitro and in silico services. IBS develops digital tools and services for the cosmetics and pharmaceutical industries. Computational Toxicology, in vitro toxicology , Safety assessment, Drug Discovery, Molecular Modeling, Computational Chemistry, CPSR, Pre Clinical screening, ADME, and PBPK Type: | 3 | 2 | 0 | 4 |
 | Diabeloop Medtech seeking to reduce the mental burden associated with diabetes thanks to interoperable self-learning solutions⚡ We want to provide people living with diabetes with an intelligent therapeutic system to regulate blood glucose. This project was initiated in 2011 by the CERITD (Centre d’Études et de Recherches pour l’Intensification du Traitement du Diabète) in collaboration with the CEA LETI. After the success of the clinical trials in 2014, we created Diabeloop to bring the project to market and make it available to the largest number of people. Since spring 2021, DBLG1 System, the first automated insulin delivery device, is being marketed … Type: | 42 | 20 | 20 | 107 |
 | ENDODIAG Founded in 2011, Endodiag is specialized in the development of products and services aimed at improving the diagnosis of endometriosis, a complex and poorly known disease, affecting yet 10% of women of reproductive age (over 180 million patients worldwide!). Located in Evry, France, within Genopole, the French largest Biocluster, the company leverages the experience of its scientific cofounders who have been working in this field for over 20 years and a network of major hospital centres both in France and abroad. Although endometriosis is a major cause of subfertility (40% of affected patients are infertile) and chronic pain, it takes … Type: | 8 | 6 | 0 | 6 |
 | DNA Script Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM️, the world’s first benchtop DNA printer powered by enzymatic technology. With continued advancement and innovation, we believe DNA Script’s enzymatic DNA synthesis technology is poised to become the engine of genomics research and personalized medicine. Synthetic Biology, Biotechnology, DNA synthesis, Sciences, Research, Development, Start-up, and Technology Tags: FrenchTech120 FrenchTech2030 Type: | 44 | 16 | 31 | 182 |
 | PathoQuest A global CRO providing NGS-based Quality Control testing for rapid and safe release of biotherapies to patients. PathoQuest is a global CRO providing NGS-based Quality Control testing through its iDTECT® platform of assays for rapid and safe release of biotherapies to patients. Validated and accepted GMP assays for viral safety and genetic characterization of raw materials, cell and gene therapies, mAbs & vaccines. Testing available in Paris (France) and in Wayne PA. Biologics Testing, Biosafety Testing, Biologics Quality Testing, Biologics QC based on Next Generation Sequencing (NGS), Viral Safety, Genetic Characterization, Testing for Clone selection, Genetic Stability Testing, Release Testing … Type: | 1 | 0 | 1 | 55 |
 | AXELIFE [Automatic translation follows] Expertise - Prevention - Innovation Axelife is a 100% French Medtech company specializing in the field of cardiovascular risk assessment and prevention. We design and develop assessment and prevention solutions, our first medical device: the pOpmètre, measures the Gold Standard pulse wave velocity for measuring arterial stiffness. The MD is class IIa and the company is ISO 13485. Our scientific team is working on algorithms to calculate arterial age and has participated in the publication of more than 30 scientific publications that have supported the interest in measuring arterial stiffness. Type: | 46 | 8 | 14 | 14 |
 | POLYVALAN Proteins Structures Got Easier With Crystallophores Emerged from academic research, POLYVALAN (IBS & ENS Lyon Spin-off company) is a young innovative company founded in December 2016 dedicated to structural biology. POLYVALAN competitive edge is its unique chemical approach allowing significant gain of effectiveness, time and/or precision for protein structure determination that allows an optimal use of the existing large equipments. structural biology, protein crystallization, crystallization screening, nucleating agent, phasing agent, crystallophore, structure determination, X-ray crystallography, and drug design Type: | 2 | 1 | 0 | 3 |
 | MaaT Pharma The leading microbiome company in oncology MaaT Pharma has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases. Committed to treating blood cancers and graft-versus-host disease, a serious complication of allogeneic stem cell transplantation, MaaT Pharma has already achieved proof of concept in acute myeloid leukemia patients. Supporting the further expansion of our pipeline into larger indications, we have built a powerful discovery and analysis platform to evaluate drug candidates, determine novel disease targets and identify biomarkers for microbiome-related conditions. Our therapeutics are produced through a standardized cGMP manufacturing and quality control process … Type: | 36 | 14 | 31 | 82 |
 | iThylo iThylo supports companies on all alcohol issues : prevention, screening, follow-up iThylo is the first connected ethylotest. For professionals, it allows companies to ensure that their employees are able to work in the best possible conditions. The iThylo team's mission is to manage risks in companies. To contact us hello@ithylo.com Informatique, Objets connectés, Securité, Prévention, Pilotage des risques, Ethylotest connecté, Accompagnement, medtech, Dispositifs Médicaux connectés, dépistage, alcool, alcohol, drogue, and drug Type: | 7 | 2 | 5 | 22 |
 | Sensorion Our mission: find solutions for hearing disorders Sensorion is a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders Its clinical-stage portfolio includes one Phase 2 product: SENS-401 (Arazasetron) progressing in a planned Phase 2 proof of concept clinical study of SENS-401 in Cisplatin-Induced Ototoxicity (CIO) and, with partner Cochlear Limited, a study of SENS-401 in patients scheduled for cochlear implantation. Sensorion has entered into a broad strategic collaboration with the Institut Pasteur focused on the genetics of hearing. It has two gene therapy programs … Type: | 15 | 9 | 6 | 77 |
 | Technoflex The IV drug-delivery expert Technoflex is the independent leader in the design, production and commercialization of I.V. drug delivery bags (standard or customized) and connectors with FDA and EMEA references. With a devoted R&D team, Technoflex offers a specific high value opportunity of taylored products to its partners. Type: | 6 | 2 | 3 | 134 |
 | SQI Fostering medical innovation For a safer and more effective healthcare, come develop tomorrow’s technological solutions with us. Software development of medical technologies: From proof of concept to certified product, we design, develop and test your medical devices software, in compliance with IEC 62304. Surgical planning | Guidance of surgical gestures | Medical robotics | Healthcare data & business wokflow management Tailor-made support for quality and regulatory affairs, from research to market: Certify your medical innovation in the best optimized and most secure way. Regulatory strategy | Clinical investigation | CE/FDA certification Développement de logiciels médicaux / applications cliniques , Quality … Type: | 10 | 4 | 8 | 82 |
 | Voxcan Animal Medical Imaging Services Voxcan is a CRO specialized in non-invasive high-resolution imaging for non-clinical drug development, based in Lyon, France.Voxcan’s core businesses have been in oncology, viral and bacterial infectious diseases, osteo-articular inflammatory diseases and medical devices for 16 years, performing efficacy, biodistribution, mechanistic and proof of concept studies based on in vitro and in vivo models combined with high-resolution imaging in a wide range of small animal species. Voxcan joined the ERBC group in July 2023, giving access to its clients to a full range of non-clinical expertises. This acquisition is in line with ERBC's 3R policy and … Type: | 6 | 1 | 5 | 16 |
 | IndyHumane Adoptions, foster, volunteer & youth programs, low-cost vaccines & spay/neuter. We've been saving lives since 1905. IndyHumane provides direct services for cats and dogs, including adoption, foster home placement, positive reinforcement behavior training for adoptable animals, appropriate medical care, and affordable spay/neuter and low-cost vaccination services to the public. In 2019, supported by more than 600 volunteers, we provided services to more than 10,000 dogs and cats, found loving homes for more than 3,800 homeless pets, and achieved a live release rate of 96%. As a limited intake shelter, we take in as many animals as we can save every … Type: | 3 | 1 | 3 | 75 |
 | Labovet Produtos Veterinários [Automatic translation follows] For over 30 years, we have been a reference in the production of vaccines and veterinary products. We are proud to be 100% Brazilian. Labovet is a pharmaceutical company that offers medicines and vaccines for small, medium and large animals. For over 30 years, our focus has been on animal health, through products with high quality standards and constant investments in research and modernization of our factory. We operate throughout Brazil with distribution centers in strategic locations in the country, in order to have the best delivery conditions and guarantee the proper packaging of our products. Biologicals, … Type: | 0 | 0 | 0 | 181 |
 | Takeda in Belgium Better Health, Brighter Future Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 230 years of distinguished history, originating in Japan. As a global leader with presence in over 80 countries and regions, our therapeutics focus on Gastro-enterology, Oncology, Rare Diseases, Neuroscience, Plasma-Derived Therapies and Vaccines. In Belgium, Takeda is one of the 10 largest pharmaceutical companies, with its local head office located in Zaventem, close to Brussels Airport. Day after day, our … Type: | 5 | 2 | 3 | 257 |
 | BePharBel Manufacturing SA HELPING CREATE A HEALTHIER WORLD THROUGH EXCELLENCE As CDMO (Contract and Development Manufacturing Organization), BePharBel Manufacturing contributes to improve the health of all by supplying our pharma partners: - a genuine end-to-end development and manufacturing solution - that facilitates and accelerates drugs availability for patients. Our main activities are: 1) CDMO BePharBel Manufacturing provides an integrated end-to-end solution for the development and manufacturing, under European GMP conditions, of drugs (small molecules and antibiotics) and medical devices. Our expertise field is the development of new formulations and drug formulations over more than 10 different sterile and non-sterile galenic forms (injectables, powder … Type: | 0 | 0 | 0 | 95 |
 | Biomeca® Creator of solutions *A deep expertise in Biomechanics and Surface Analysis in Life Science* Living systems has to be considered as physical systems so that unravelling the physical mechanisms involved in complex biological processes and diseases is one of the main challenges of biology. In BioMeca we believe that the starting point is to give a quantitative physical description of biological samples to have a better understanding of such processes. BioMeca® is a company based in Lyon expert in biomechanics and mechanobiology and specialized in high-resolution structural and mechanical characterization of biological samples at different scales, from large structures, such … Type: | 8 | 3 | 5 | 7 |
 | ENTEROSYS - Gut Is The Link Preclinical studies in gut and gut brain for therapies of tomorrow 🔬 About ENTEROSYS At ENTEROSYS, we are science enthusiasts 🧪 driven by a conviction deeply rooted in medical history: for over two millennia, it has been acknowledged that the key to understanding many diseases lies in our digestive system and its interactions with other organs. Based on this ancient wisdom, we have embraced a modern and holistic approach focused on digestive physiology and the communication between the gut and peripheral organs. Specializing in the preclinical evaluation of compounds with therapeutic potential 💊, we utilize cutting-edge techniques to analyze physiological … Type: | 1 | 1 | 0 | 10 |
 | IPRASENSE Cell Culture Monitoring Instruments IPRASENSE revolutionizes cell analysis with innovative technologies for automated cell counting and real-time visualization, ideal for research and quality control. Cell culture monitoring, Lensless Lensfree Imaging, Video microscopy, Time lapse Imaging, Automatic cell count and viability analysis, High throughput cell, Inside your incubator, cell count, cell counting, cell viability, cell viability analysis , cell monitoring, and angiogenesis Type: | 1 | 0 | 0 | 6 |
 | SC MEDICA SC MEDICA is a global leading spinal facet fixation company, dedicated to providing innovative solutions for back pain control and spinal fusion. With a commitment to excellence and innovation, SC MEDICA strives to advance standards of care and address unmet patient needs. Our mission: Raise awareness about the role of facet joints in a large number of spinal conditions. Make FFX® fusion a gold standard. Worldwide. Type: | 1 | 1 | 0 | 8 |
 | SkinDermic Clinical stage biotech company with innovative first-in-class new treatments in virology and dermatology SkinDermic® is a drug discovery company focused on developing breakthrough and innovative small molecule drugs for the treatment of HHV8 virus linked neoplasia and inflammatory skin diseases. SkinDermic® recently completed proof of concept clinical phase in humans with its First-in-Class treatments for acne and HHV8 associated diseases (Kaposi Sarcoma and Lymphomas). Skindermic owns now a pipeline with very active and very well tolerated new drugs for HHV8 associated diseases and acne vulgaris. Type: | 0 | 0 | 0 | 5 |
 | The Twinkle Factory Stain Different. Tag FAST. The Twinkle Factory offers exclusive twinkling reagents for life science research: flurogenic ligands for FAST and split FAST, protein fluorescent reporters, and fluorogenic molecular glues for CATCHFIRE, a self reporting protein dimerizer. Protein-protein interactions, high content analysis, anaerobe metabolic engineering, are our users keywords. The Twinkle Factory is dedicated to speed-up the dissemination of breakthrough fluorescent technologies across the life sciences community. molecular glues, protein-protein interactions, and fluorescent proteins Type: | 0 | 0 | 0 | 6 |
 | Adjuvatis Built around safe-by-design concept, Adjuvatis is committed for innovative formulations to improve pharmaceuticals Adjuvatis, a French startup in biotechnology, develops innovative safe-by-design delivery systems to help laboratories and pharmaceutical companies in vaccine formulation as adjuvants and in drug delivery as vectors for oncology, dermatology, infections, etc. Our first technology, called i-Particles®, is based on 200 nm-diameter particles composed of poly-lactic acid only (any surfactant and solvents) for formulation of hydrophobic molecules in the particle core and surface functionalization of peptides. Our second technology, i-LipoP®, consists in i-Particles® covered by lipidic bilayers at their surface for vectorization of nucleic acids and … Type: | 2 | 0 | 2 | 4 |
 | SynHelix (now Quantoom Biosciences, a Univercells Company) Large-scale DNA synthesis technology that harnesses natural enzymes. Since January 2022, SynHelix is part of Quantoom Biosciences. Please go to the Quantoom Biosciences Linkedin page or www.quantoom.com for more information. Molecular biology, synthetic biology, biotechnology, Biochemistry, Surface chemistry, lifesciences, computational biology, gene synthesis, gene therapy, cell therapy, bioeconomy, enzymology, Biocatalysis, Bioengineering, Enzyme engineering, Biotherapeutics, Protein engineering, Recombinant proteins, and nanotechnology Type: | 2 | 2 | 1 | 7 |
 | OxiProteomics Innovative scientific services on efficacy testing for bioactives or formulated products to support healthy aging. OxiProteomics is a technology-based start-up committed to promoting the healthy living and healthy aging of human population. We deliver proven science services to dermo-cosmetic and food industries to support marketing claims. We also offer environmental quality bio-monitoring solutions to promote sustainable development. OxiProteomics patented technologies are based on the direct and specific detection of functional high quality proteins vs. oxidatively damaged (carbonylated) in biological samples, with a remarkably specificity and sensitivity. We can detect and quantify for the first time, the quality of thousands proteins … Type: | 3 | 1 | 2 | 14 |
 | G.CLIPS biotech ENABLING TECHNOLOGY FOR THERAPEUTICS TARGETING MEMBRANE PROTEINS G.CLIPS biotech created the first enabling technology to unravel the potential of drug and antibody candidates on pathology-like format membrane proteins to be used in screening efforts, characterization, structural studies, mechanism of action, pharmacological profiling and target validation. We offer a unique technology to express, stabilize, select and validate membrane proteins as targets based on proprietary G.Screen® Platform. G.Mixes® G.Select® Assay G.Lipidomics® G.Validation® Assay We provide tailor-made services to pharma, biotech and animal health companies targeting membrane proteins (GPCRS, Receptors, Transmebrane Proteins) that would like to ascertain the necessary environment and conformation stabilization … Type: | 12 | 2 | 6 | 6 |
 | CLARTEIS Clarteis is a global specialist in the miniaturization and manufacture of medical devices dedicated to dermatology. CLARTEIS is a global leader in manufacturing advanced and innovative technologies for the Dermatological market. CLARTEIS team is specialized in developing miniaturized and high quality light-based medical devices to provide to Dermatologists worldwide. Type: | 0 | 0 | 0 | 10 |
 | AnatomikModeling 3D custom made implants AnatomikModeling creates 3D custom-made implants for Reconstructive&Aesthetic Surgery, Pneumology and Maxillofacial Surgery. Our 3D custom-made implants are designed for Pectus Excavatum, Poland Syndrome and others anatomy defects like hard or soft tissues loss. Medical Devices, Reconstructive surgery, Pectus Excavatum surgery, Poland Syndrome surgery, and 3D CAD CAM Medical implants Type: | 0 | 0 | 0 | 4 |
 | IPSOMEDIC Innovative Process Solutions IPSOMEDIC is a pharmaceutical development company, specializing in innovation in the manufacturing of active pharmaceutical ingredients (APIs). Our objective is to give countries the possibility to reach their pharmaceutical independance. We design tailor-made processes for all stages of industrial production, to become cost efficient, environmental-friendly, and safe: - Continuous chemical reaction - Continuous purification - Continuous crystallization Innovation, Chemical processes, drug substance, and Continuous processes Type: | 2 | 0 | 0 | 17 |
 | Syntivia Preclinical and R&D expertise for skin health care Syntivia is a research laboratory that creates and develops active compounds for dermatology and cosmetics in partnership with its customers. Our experts use the latest chemistry and extraction tools and techniques to create effective active compounds. We develop our own skin models and use the latest cellular/molecular biology and imaging techniques to build solid scientific dossiers demonstrating product efficacy. Syntivia est Laboratoire de rechercher qui créé et développe en partenariat avec ses clients des composés actifs pour la dermatologie et la cosmétique. Nos experts mettent en œuvre les derniers outils et techniques … Type: | 0 | 0 | 0 | 10 |
 | INFYNITY BIOMARKERS SAS Maximizing Immunoassays Performances InfYnity Biomarkers was founded in 2009 in Lyon (France). We are an R&D In-Vitro Diagnostics Company fully dedicated to infectious diseases and immunity. Company Mission: Maximizing Immunoassay Performance i.e. we have the ambition to set new criteria for immunoassays: study the diversity of immune response to provide high-value information instead of the binary response. Our Offer: - High quality, custom-made biomaterial (antigens and antibodies) - RUO Multiplex Immunoassays - Tailored immunobiology services ranging from biomaterial design to biomarker discovery and immunoassay development. Our originality and strength relies on a unique combination of proven skills: Multiplex technology AND … Type: | 0 | 0 | 0 | 6 |
 | Selexis SA Global Leaders in Mammalian Cell Line Development KBI Biopharma and Selexis SA are consolidating operations as one organization under the KBI Biopharma name. This streamlined approach supports customers in accelerating drug development and manufacturing, creating greater flexibility, efficiencies, and a simplified partner experience. You can follow us on the KBI Biopharma page to stay up-to-date on the latest news, events, and happenings. Cell Line Development, HTS, Cell Line Engineering, Contract Biological Services, Stable Cell Line Development, Cell Engineering, Variant Screening, Research Cell Banks, Monoclonal Antibodies, Whole Genome Sequencing, Bispecific Antibodies, CDMO, Monoclonality Assessment, Biotechnology, Biosimilars, Cell line engineering, Genetic engineering, … Type: | 4 | 1 | 0 | 31 |
 | Plexus Ventures LLC Plexus Ventures is a prominent healthcare advisory boutique. Our team of professionals are located in markets all over the world – the United States, Europe, and the Asia-Pacific market, including China and Japan – enabling us to combine local knowledge with global reach. pharmaceutical, drug delivery, biotechnology, consumer & OTC, business development & consulting, out-licensing, in-licensing, divestments, acquisitions, global pharmaceutical market experts, marketing & sales, project management, biosimilars, medical device, and consultants Type: | 38 | 0 | 38 | 16 |
 | Lockwood Lockwood collaborates with clients in the pharmaceutical, biotech, and medical device industries to identify effective, holistic, science-based strategies to address their objectives through medical and market access communications. Our clients count on us to challenge their assumptions, and help them creatively navigate around obstacles. From strategy through execution, we focus on accuracy, transparency, and scientific value to create programs that are evidence-based, clinically relevant, and contribute to the development of our clients’ brands. Over a third of our staff hold advanced scientific or medical degrees, and most work from where they live. Because our flexible structure provides better work-life balance, … Type: | 3 | 0 | 2 | 398 |
 | Paratek Pharmaceuticals Developing transformative solutions for patients with infectious diseases and other difficult to treat conditions Positive outcomes. Positive patient stories. These are our priorities at Paratek Pharmaceuticals. As a commercial-stage biopharmaceutical company, we develop transformative solutions for patients with infectious diseases and other difficult to treat conditions, and we believe that we have the right people, the right knowledge and the right drug to make a difference in patients’ lives. Our Mission To create positive stories for patients, physicians and caregivers based on trust and integrity. To accomplish this, our employees work hard to turn everyday decisions into everyday triumphs that … Type: | 6 | 0 | 6 | 332 |
 | mAbxience From lab to life mAbxience is a Spanish-based company specializing in the development, production, and commercialization of biopharmaceuticals. With over a decade of expertise, our mission is clear: to provide accessible, affordable medicines across the globe, aiming to enhance the quality of life by ensuring universal access to high-caliber medicines. With two market-approved products and a robust pipeline in development, we have established a B2B presence in over 100 markets. Alongside this, we have formed a network with more than 30 partners and built a dedicated team of over 1,000 professionals. Our three multi-product facilities, located in Europe and South … Type: | 6 | 2 | 3 | 984 |
 | UroGen Pharma UroGen Pharma is a biotech company that builds novel solutions to revolutionize the way specialty cancers and urologic diseases are treated – because patients deserve better options. Our vision is grounded in our RTGel® drug delivery technology, our promising pipeline, and a collaborative drive for bold results. Our existing technology: the RTGel drug delivery technology has the potential to be applied to a variety of unmet medical needs. RTGel reverse-thermal hydrogel is liquid at lower temperatures and converts to gel form at body temperature, offering the opportunity to make local therapy a more effective treatment. Our promising pipeline: Ranging from … Type: | 1 | 0 | 1 | 238 |
 | Genovis We help Scientist build knowledge about their Biopharmaceuticals with our SmartEnzymesTM! Genovis offers a unique range of rapid and easy to use enzymatic tools primarily for the biopharmaceutical industry. Available worldwide, these SmartEnzymesTM are supplied in innovative formats for the development, production and quality control of biological drugs such as monoclonal antibodies, ADCs, biosimilars and bispecifics. The Genovis SmartEnzymes are widely used for the digestion, de-glycosylation and conjugation of the target molecule and are an ideal companion to popular analytical techniques like LC-MS. Within the portfolio there are enzymes specific for: IgG digestion - FabRICATORTM, FabALACTICATM, GingisKHANTM, FabULOUSTM & FabRICATOR … Type: | 1 | 0 | 0 | 42 |
 | Orexo AB publ Improves lives for patients suffering from mental illness and substance use disorder 💚 Orexo is a Swedish pharmaceutical company with over 25 years of experience developing improved pharmaceuticals based on proprietary formulation technologies that meet large medical needs. On the US market, Orexo provides innovative treatment solutions for patients suffering from opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with leading partners. Total net sales in 2022 amounted to SEK 624 million, and the number of employees to 126. Orexo is listed on Nasdaq Stockholm's main list and is available as an … Type: | 6 | 1 | 3 | 97 |
 | Medicines for Malaria Venture Ending malaria, rewriting the future MMV is a leading product development partnership (PDP) in the field of antimalarial drug research and development. Our vision is a world in which innovative medicines will cure and protect the vulnerable and under-served populations at risk of malaria, and ultimately help to eradicate this terrible disease. Our success in research and access & product management comes from our extensive partnership network of over 375 pharmaceutical, academic and endemic-country partners in 50 countries. www.mmv.org www.facebook.com/medicinesformalaria www.twitter.com/medsformalaria www.youtube.com/user/MMVmeds4malaria http://plus.google.com/+mmvorgmedsformalaria Research and Development, Product Development Partnership (PDP), Medicines, and Malaria Type: | 13 | 4 | 9 | 161 |
 | Symphogen Symphogen A/S, a Servier company and the Centre of Excellence for Antibodies, operates within in research, early clinical stages and CMC biologics development from research to market. Supporting Servier’s commitment to improve patients health and the R&D strategy within oncology and immune-oncology - Symphogen’s strategic focus is to apply our streamlined and effective antibody platform and capabilities in the discovery and early development of highly differentiated antibodies. The aim is to develop novel compounds either as combination or as stand-alone therapies for difficult to treat cancers. oncology, immune-evasive, and AXL Type: | 0 | 0 | 0 | 189 |
 | STERIS Healthcare United States STERIS offers customized solutions for a variety of environments, including the SPD, OR, GI/Endoscopy Suite, and ASC. STERIS Healthcare partners with Customers in the perioperative environment to help elevate patient care in Operating Rooms, GI / Endoscopy Suites, and Sterile Processing Departments across the globe. Our team of advisors puts Customers and their patients first. Through comprehensive solutions in equipment, consumables, devices, and services, we help Customers solve their biggest challenges, leverage opportunities for future growth, and advance the care of patients every day. Type: | 0 | 0 | 0 | 2 |
Startup